Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Poloxamer 188
CAS 691397-13-4
Concern score
Not assessed — no hazard data yet.
Why it's flagged
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 4 mg
Regulation
No restrictions found. Poloxamer 188 appears in these published regulatory listings.
- definition_level:incomplete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:ingredient substance
- substance_class:polymer
- substance_type:polymer
USFDAinactive ingredient database22 entries — 6 administration routes
- Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 4 mgSource →
- Route: INTRAMUSCULAR; Dosage form: POWDER, FOR SUSPENSION; Potency: 0.2 %w/vSource →
- Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 6 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 2.2 mgSource →
- Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.1 %w/vSource →
- Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 151 mgSource →
- Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 18 mgSource →
- Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 3 mgSource →
- Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 81 mgSource →
- Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Maximum daily exposure: 624 mgSource →
- Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 500 mgSource →
- Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 30 mgSource →
- Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1800 mgSource →
- Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1600 mgSource →
- Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 6 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 100 mgSource →
- Route: ORAL; Dosage form: TABLET, COATED; Potency: 3 mgSource →
- Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 6 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 37 mgSource →
- Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 3 mgSource →
- Route: PERIODONTAL; Dosage form: GEL; Potency: 55 mgSource →
- Route: TOPICAL; Dosage form: CREAM; Potency: 1 %w/wSource →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as polymer.
- openFDA substance registry classifies this ingredient as polymer.Source →
Evidence
No graded sources yet for Poloxamer 188. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Found in these products
- Morning Fresh Dishwashing Liquid Lemon 400mlMorning fresh
- Equate oral rinseHigh
- Morning Fresh Dishwashing Liquid Original 400mlMorning fresh
- Morning Fresh Dishwashing Liquid Tropical CrushMorning fresh
- Morning Fresh Dishwashing Liquid Strawberry & Guava 400mlMorning fresh
- Hydro Boost Gentle Cleansing LotionNeutrogena
- power swabsHigh
- LACALUT aktivLACALUT · HygieneHigh
- BexidentISDIN · Non Food ProductsHigh
